Français📈 See the interactive version (live chart) →
| Investment | Value today | Gain |
|---|---|---|
| 1 years ago (2025) | $852 | -15% |
| 3 years ago (2023) | $936 | -6% |
| 5 years ago (2021) | $917 | -8% |
| 10 years ago (2016) | $3,630 | +263% |
| since 1995 | $226,763 | +22576% |
| Year | Year's return | $1,000 invested at year start → worth today |
|---|---|---|
| 2026 (YTD) | -19% | $809 (-19%) |
| 2025 | +5% | $852 (-15%) |
| 2024 | +33% | $1,133 (+13%) |
| 2023 | -17% | $936 (-6%) |
| 2022 | -20% | $748 (-25%) |
| 2021 | +23% | $917 (-8%) |
| 2020 | +37% | $1,258 (+26%) |
| 2019 | +36% | $1,711 (+71%) |
| 2018 | +34% | $2,301 (+130%) |
| 2017 | +36% | $3,141 (+214%) |
| 2016 | +16% | $3,630 (+263%) |
📊 See the analyst analysis of ResMed →
$1000 invested in ResMed 5 years ago would be worth $917 today, and $3,630 over 10 years (price return, excluding dividends).
Calendar-year returns — 2024: +33%. 2025: +5%. 2026: -19%. Full breakdown in the table above.
Over 10 years, ResMed's average annual return (CAGR) is about 14% per year, and -2%/yr over 5 years.
Best year: 2020 (+37%). Worst year: 2022 (-20%).
It's proportional — just multiply. Over 5 years, $1,000 invested in ResMed is worth $917, so $100 would be worth a tenth, $5,000 five times more, and $10,000 ten times more. Use the calculator at the top of the page for your exact amount and chosen year.
JPI Invest aggregates analyst recommendations across the entire S&P 500 (plus the S&P MidCap 400), replays them against real prices and measures who predicts best — on results, not reputation. Instead of taking a price target at face value, you see each analyst's track record on each stock.
⚠️ Past performance, no predictive value and not investment advice. Prices in $, excluding dividends. Data: Yahoo Finance.